Expiration of Medicare Telehealth Coverage
H.R. 5371, also known as the “Continuing Appropriations and Extensions Act of 2026” would have extended telehealth flexibilities through November 21, 2025. Congress was not able to pass this legislation […]
Cochlear North America Wins Dual Honors at 2025 Hearing Health & Technology Matters Innovator Awards
LONE TREE, CO — October 6, 2025 — Cochlear North America is proud to announce its recognition as a gold winner in two categories at the prestigious 2025 Hearing Health […]
Quick Tip: Programming a Replacement Baha® Sound Processor
Welcome to Cochlear™ Quick Tips. The purpose behind Quick Tips is to give you “bite-sized” information that you can use when working with our products. In this edition, we will discuss how to […]
Cochlear™ Nucleus® Nexa® System – the Future of Hearing. Available Now!
Cochlear is now accepting orders for the Nucleus® Nexa® System. Shipments for the Nucleus Nexa System will begin today, August 26, 2025. The recommended earliest day to schedule surgeries is […]
An Examination of Innovation: The Science Behind the Cochlear™ Osia® System
We recently interviewed Henrik Fyrlund, Manager of Advanced Acoustics and the Acoustics Portfolio Lead at Cochlear, to debunk some common myths about active bone conduction systems by discussing the science […]
Science Spotlight: Multicenter SmartNav Study Comparing Placement Check to Intraoperative Imaging
Proper placement of an electrode array is essential for maximizing postoperative performance outcomes with a cochlear implant. Imaging is typically the standard of care for confirming proper electrode placement; however, […]
Quick Tip: Programming a Replacement Osia® Sound Processor
Welcome to Cochlear™ Quick Tips. The purpose behind Quick Tips is to give you “bite-sized” information that you can use when working with our products. In this first edition, we […]
Cochlear Launches World’s First and Only Smart Cochlear Implant System
[LONE TREE, CO, July 8, 2025]: Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of the Cochlear™ […]
Congenital CMV: An Important Topic for All Hearing Healthcare Professionals
Written by Guest Author, Dr. Abby Meyer, MD, MPH, FAAP Congenital cytomegalovirus (cCMV) infection is the most common congenital infection with an estimated prevalence of approximately 1 in 200 births. […]
Cochlear introduces the Baha® 7 Sound Processor and Baha SoundBand™
[LONE TREE, CO] – June 2, 2025: Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announces today the commercial release of the new Cochlear™ Baha® 7 Sound […]
End of content
No more pages to load